2
  C   P   D    w   h   i   l  s  t    h  a   v   i  n  g   a    w   e  e  :    T   H   E    B  O  G    B   L  O  G  :  A technical update - July 2015 v1.0 Understanding Nicotine receptors We are all born with nicotine receptors: when triggered, they release dopamine, the “happy hormone”. But then dopamine levels quickly dip below baseline, person feels low & anxious, so they smoke more. The dips in mood caused by quitting smoking are acute. Regular smoking leads to a 300x-increase in nicotine receptors, so for most smokers, smoking is a “chronic relapsing organic brain disease” - not a lifestyle choice. Why quitting is so difficult It takes 24-48 hours for nicotine to leave the body, but 6-8 weeks for nicotine receptors to be down-regulated. The period in-between is “hell”. This is why only 2-3% of smokers succeed in quitting each year (and note that “success rates” are validated by one-year quit rates). Willpower + pharmacotherapy enables 4-6% to quit, trained support + willpower 10-15% but best of all is trained support + pharmacotherapy , the combination achieving 20-30% quit rates. The “trained support” needs to be available, accessible, empathetic & non-  jud gem ental & tra ined in moti vat ional int erv iew in g. The problem with “advice to stop smoking” This is a negative message, you inevitably sound like you’re nagging, it’s not new information, frustrat es both doctor and smoker and encourages conflict and denial. And because it doesn’t work, so you’re discouraged from doing it again! So instead, Alex advocated the concept of “Very Brief Advice” (VBA)  for smokers: 1. Establis h & rec ord sm okin g stat us (a QOF point) 2. Advi se how to sto p - “bes t way i s wit h support & treatment” 3. Off er s uppor t & trea tment (QOF ). Note that VBA deliberately does not   advise them to stop, ask how much or what they smoke, or even ask if they want to stop (they nearly all want to stop). It’s completely the opposite of a “smoking history”! The advantages of VBA are many. It’s quick (under 30 seconds), records smoking status (important, as even with optimal help, 70%+ will relapse), opportunistic, positive, avoids nagging, is informative, engaging - for most it’s new information, is evidence based, and satisfies QOF. It is, however, not a smoking cessation consultation - that’s the next step, at which you have to get across that “it’s the nicotine that makes you smoke, but the smoke that kills you” - and how vital it is to take not one single puff “or you’ll wake up the nicotine receptors you’re trying to switch off” The drug options As well as NRT (see box, right) there are two other pharmacologi cal options:  Bupropion (Zyban)  300mg OD for 10 weeks modifies dopamine levels & noradrenergic activity, significantly increasing odds of a successful quit (1.94 LR) but is now rarely used, mostly due to scare stories in the Daily Mail - though it’s safety is comparable to SSRIs. It’s still a valid choice, but not as good or safe as Champix. Champix (verenicline)  is a partial nicotine agonist that both blocks & stimulates nicotine receptors - it reduces the hit if the smoker does takes a sneaky puff, but also reduces withdrawal symptoms. Main problem is nausea - about one third of patients, tackled by adjusting dose, anti-emetics, and taking it with food & water. There are no clinically meaningful drug interactions, but it’s contraindicated  i n ESRF, under 18s and pregnancy, and caution  in mental health problems and breastfeeding. However , MH patients have much more to gain from quitting: monitoring is required during a Champix-facilitated quit attempt, but there’s no evidence of higher rates of fatal/non fatal self-harm or depression cf. NRT. Here are some (belated!) notes from 12 Dec 2014 Ysbyty Gwynedd Grand Round - v good session Feedback to this Bog Blog? Contact Linda Dykes (Consultant in EM & occasional locum GP!) Email [email protected] - www.mountainmedicine.co.uk  !" "$%&' ()* ($+,-./0 12345!6 (7118 953!  9 $%: ;< *= 8%&> ?@;$: The scale of the problem Cigarettes are a weapon of mass destruction and a drug delivery system. It takes 7-10 seconds for nicotine to hit the brain after inhaling - like a potentiated intra-arterial drug delivery system (IV takes 3040 seconds). Smoking is the single largest cause of premature death and over 50% of smokers die prematurely, often after decades of morbidity. Nicotine replacement Therapy - Nine different forms - the best is the one the smokers wants to use - The “hit” is slower and less addictive, significantly reducing withdrawal symptoms and cravings cf. placebo. - OR of successful quit vs. placebo = 1.77. - Treat for 8-12 weeks with gradual withdrawal - don't stop early. Also need to use enough: avoid under- dosing and irregular use. NB: e-cigarettes not yet recommended.

Smoking Cessation Bog Blog v1.0

Embed Size (px)

DESCRIPTION

Report from an Ysbyty Gwynedd Grand Round in December 2014, speaker Dr Alex Bobak.

Citation preview

  • CPD whil

    st

    hav ing a

    w ee:

    THE BOG

    BLOG:

    A technical update - July 2015 v1.0

    Understanding Nicotine receptors We are all born with nicotine receptors: when triggered, they release dopamine, the happy hormone. But then dopamine levels quickly dip below baseline, person feels low & anxious, so they smoke more. The dips in mood caused by quitting smoking are acute. Regular smoking leads to a 300x-increase in nicotine receptors, so for most smokers, smoking is a chronic relapsing organic brain disease - not a lifestyle choice.

    Why quitting is so difficult It takes 24-48 hours for nicotine to leave the body, but 6-8 weeks for nicotine receptors to be down-regulated. The period in-between is hell. This is why only 2-3% of smokers succeed in quitting each year (and note that success rates are validated by one-year quit rates). Willpower + pharmacotherapy enables 4-6% to quit, trained support + willpower 10-15% but best of all is trained support + pharmacotherapy, the combination achieving 20-30% quit rates. The trained support needs to be available, accessible, empathetic & non-judgemental & trained in motivational interviewing. The problem with advice to stop smoking This is a negative message, you inevitably sound like youre nagging, its not new information, frustrates both doctor and smoker and encourages conflict and denial. And because it doesnt work, so youre discouraged from doing it again!

    So instead, Alex advocated the concept of Very Brief Advice (VBA) for smokers:1. Establish & record smoking status (a QOF point)2. Advise how to stop - best way is with support &

    treatment3. Offer support & treatment (QOF).

    Note that VBA deliberately does not advise them to stop, ask how much or what they smoke, or even ask if they want to stop (they nearly all want to stop). Its completely the opposite of a smoking history! The advantages of VBA are many. Its quick (under 30 seconds), records smoking status (important, as even with optimal help, 70%+ will relapse), opportunistic, positive, avoids nagging, is informative, engaging - for most its new information, is evidence based, and satisfies QOF. It is, however, not a smoking cessation consultation - thats the next step, at which you have to get across that its the nicotine that makes you smoke, but the smoke that kills you - and how vital it is to take not one single puff or youll wake up the nicotine receptors youre trying to switch offThe drug options As well as NRT (see box, right) there are two other pharmacological options: Bupropion (Zyban) 300mg OD for 10 weeks modifies dopamine levels & noradrenergic activity, significantly increasing odds of a successful quit (1.94 LR) but is now rarely used, mostly due to scare stories in the Daily Mail - though its safety is comparable to SSRIs. Its still a valid choice, but not as good or safe as Champix. Champix (verenicline) is a partial nicotine agonist that both blocks & stimulates nicotine receptors - it reduces the hit if the smoker does takes a sneaky puff, but also reduces withdrawal symptoms. Main problem is nausea - about one third of patients, tackled by adjusting dose, anti-emetics, and taking it with food & water. There are no clinically meaningful drug interactions, but its contraindicated in ESRF, under 18s and pregnancy, and caution in mental health problems and breastfeeding. However, MH patients have much more to gain from quitting: monitoring is required during a Champix-facilitated quit attempt, but theres no evidence of higher rates of fatal/non fatal self-harm or depression cf. NRT.

    Here are some (belated!) notes from 12 Dec 2014 Ysbyty Gwynedd Grand Round - v good session

    Feedback to this Bog Blog? Contact Linda Dykes (Consultant in EM & occasional locum GP!) Email [email protected] - www.mountainmedicine.co.uk

    NW Wales CPD Catch-up SMOKING CESSATION Talk by Dr Alex Bobak

    The scale of the problem Cigarettes are a weapon of mass destruction and a drug delivery system. It takes 7-10 seconds for nicotine to hit the brain after inhaling - like a potentiated intra-arterial drug delivery system (IV takes 3040 seconds). Smoking is the single largest cause of premature death and over 50% of smokers die prematurely, often after decades of morbidity.

    Nicotine replacement Therapy- Nine different forms - the best is the one the smokers wants to use - The hit is slower and

    less addictive, significantly reducing withdrawal symptoms and cravings cf. placebo.

    - OR of successful quit vs. placebo = 1.77.

    - Treat for 8-12 weeks with gradual withdrawal - don't stop early. Also need to use enough: avoid under-dosing and irregular use.

    NB: e-cigarettes not yet recommended.